StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$61.99−1.66 (-2.61%)

Close on Nov 18, 2026Market cap $1.77BP/E 158.9Yield –

Eton Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Eton Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $105.60M, up 81.5% year over year. For fiscal 2025 it was $79.95M, up 104.9% from the year before. The highest annual figure on record is $79.95M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$79.95M+104.9%
FY2024Dec 31, 2024$39.01M+23.3%
FY2023Dec 31, 2023$31.64M+48.9%
FY2022Dec 31, 2022$21.25M-2.7%
FY2021Dec 31, 2021$21.83M+55879.5%
FY2020Dec 31, 2020$39.00K-95.9%
FY2019Dec 31, 2019$959.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$37.59M+98.6%
Q1 FY2026Mar 31, 2026$24.27M+40.4%
Q4 FY2025Dec 31, 2025$21.28M+82.7%
Q3 FY2025Sep 30, 2025$22.46M+117.5%
Q2 FY2025Jun 30, 2025$18.93M+108.6%
Q1 FY2025Mar 31, 2025$17.28M+116.9%
Q4 FY2024Dec 31, 2024$11.65M+59.3%
Q3 FY2024Sep 30, 2024$10.32M+46.9%
Q2 FY2024Jun 30, 2024$9.07M-24.4%
Q1 FY2024Mar 31, 2024$7.97M+50.2%
Q4 FY2023Dec 31, 2023$7.31M-13.9%
Q3 FY2023Sep 30, 2023$7.03M+118.3%
Q2 FY2023Jun 30, 2023$12.00M+63.0%
Q1 FY2023Mar 31, 2023$5.30M+143.8%
Q4 FY2022Dec 31, 2022$8.50M+39.5%
Q3 FY2022Sep 30, 2022$3.22M+315.4%
Q2 FY2022Jun 30, 2022$7.36M+139.9%
Q1 FY2022Mar 31, 2022$2.18M-81.7%
Q4 FY2021Dec 31, 2021$6.09M+7422.2%
Q3 FY2021Sep 30, 2021$775.00K–
Q2 FY2021Jun 30, 2021$3.07M+15235.0%
Q1 FY2021Mar 31, 2021$11.90M+11917.2%
Q4 FY2020Dec 31, 2020$81.00K-82.4%
Q3 FY2020Sep 30, 2020-$161.00K–
Q2 FY2020Jun 30, 2020$20.00K–
Q1 FY2020Mar 31, 2020$99.00K-80.2%
Q4 FY2019Dec 31, 2019$459.00K–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$500.00K–

More Eton Pharmaceuticals figures

See a number that looks wrong?